Fortune Business Insights values the global natural health medicines market at USD 71.92 billion in 2025, with growth to USD 78.65 billion in 2026 and further expansion to USD 137.49 billion by 2034. This represents a compound annual growth rate (CAGR) of 7.23% across the 2026–2034 forecast window. Natural health medicines, sometimes called herbal medicines, are products sourced from plants or animals and used to prevent or manage illness while supporting the body's own healing processes.
Europe held the largest regional share in 2025, at 38.64% of the global market, reflecting the region's long history with alternative treatments, a mature preventive-healthcare sector, and heavy reliance on imported plant-based ingredients. Leading companies named in the report include Amway Corp., General Nutrition Centers, Herbalife Nutrition, Nordic Naturals, and Wild Nutrition, among others competing for share through new product launches and portfolio expansion.
Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/natural-health-medicines-market-113152
Pandemic-Era Impact
The report notes that COVID-19 accelerated interest in preventive health. Citing research published via the U.S. National Library of Medicine, it points to a spike in multivitamin sales in March 2020, with unit sales climbing sharply as consumers stocked up on immune-support products such as vitamin C, vitamin D, probiotics, and zinc. The shift to at-home living during the pandemic also pushed more purchasing toward online and direct-to-consumer channels, a pattern that has persisted.
Growth Drivers and Restraints
Two consumer trends stand out as growth drivers: younger buyers prioritizing preventive wellness over reactive treatment, and a broader move away from synthetic supplements toward plant-based, organic, and "clean label" alternatives perceived as safer. Innovation in formulation—gummies, powders, and personalized nutrition—is helping suppliers meet this demand.
On the restraint side, volatile pricing for raw materials such as magnesium raises production costs, which get passed on to consumers and can limit adoption in price-sensitive markets like Brazil, South Africa, and India. Innovation in extraction and processing technology is flagged as a key opportunity, improving the bioavailability of natural ingredients and enabling more targeted formulations for concerns like cognitive function and heart health.
Segment Highlights
By product, vitamins and minerals led the market in 2025 and are projected to hold roughly 51.6% share in 2026, owing to broad consumer familiarity and their role in immunity and development. Natural extracts—including ginseng, ginkgo biloba, and curcumin—were the fastest-growing product category, with an anticipated CAGR of about 11%.
By form, chewables captured the largest share in 2025 (37.89%), valued for ease of use without water and broad consumer appeal, while tablets held the second position thanks to low cost, dosing accuracy, and shelf stability.
By function, energy and performance support led in 2025 and is expected to represent about 20% of the market in 2026, while brain health and cognitive support is forecast as the fastest-growing function, at roughly 12% CAGR, partly driven by remote-work-era demand for focus-related products.
By distribution channel, grocery stores were the top channel due to accessibility and pricing flexibility, expected to hold around 35.6% share in 2026, while e-commerce is projected to grow fastest, at roughly 11% CAGR, aided by convenience and price comparison.
Regional Snapshot
Competitive Landscape
The report describes a fragmented industry where global conglomerates and specialized regional brands compete through mergers, acquisitions, and partnerships with healthcare providers. Recent moves cited include SFI Health's 2025 expansion of its Equazen product line into Portugal, Wild Nutrition's first television campaign in late 2024, and Herbalife's 2023 launch of a plant-based supplement line.